Epidemiology of Diabetes and Atherosclerotic Cardiovascular Disease Among Asian American Adults: Implications, Management, and Future Directions: A Scientific Statement From the American Heart Association

Asian American individuals make up the fastest growing racial and ethnic group in the United States. Despite the substantial variability that exists in type 2 diabetes and atherosclerotic cardiovascular disease risk among the different subgroups of Asian Americans, the current literature, when avail...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Circulation (New York, N.Y.) Ročník 148; číslo 1; s. 74
Hlavní autoři: Kwan, Tak W, Wong, Sally S, Hong, Yuling, Kanaya, Alka M, Khan, Sadiya S, Hayman, Laura L, Shah, Svati H, Welty, Francine K, Deedwania, Prakash C, Khaliq, Asma, Palaniappan, Latha P
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States 04.07.2023
Témata:
ISSN:1524-4539, 1524-4539
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Asian American individuals make up the fastest growing racial and ethnic group in the United States. Despite the substantial variability that exists in type 2 diabetes and atherosclerotic cardiovascular disease risk among the different subgroups of Asian Americans, the current literature, when available, often fails to examine these subgroups individually. The purpose of this scientific statement is to summarize the latest disaggregated data, when possible, on Asian American demographics, prevalence, biological mechanisms, genetics, health behaviors, acculturation and lifestyle interventions, pharmacological therapy, complementary alternative interventions, and their impact on type 2 diabetes and atherosclerotic cardiovascular disease. On the basis of available evidence to date, we noted that the prevalences of type 2 diabetes and stroke mortality are higher in all Asian American subgroups compared with non-Hispanic White adults. Data also showed that atherosclerotic cardiovascular disease risk is highest among South Asian and Filipino adults but lowest among Chinese, Japanese, and Korean adults. This scientific statement discusses the biological pathway of type 2 diabetes and the possible role of genetics in type 2 diabetes and atherosclerotic cardiovascular disease among Asian American adults. Challenges to provide evidence-based recommendations included the limited data on Asian American adults in risk prediction models, national surveillance surveys, and clinical trials, leading to significant research disparities in this population. The large disparity within this population is a call for action to the public health and clinical health care community, for whom opportunities for the inclusion of the Asian American subgroups should be a priority. Future studies of atherosclerotic cardiovascular disease risk in Asian American adults need to be adequately powered, to incorporate multiple Asian ancestries, and to include multigenerational cohorts. With advances in epidemiology and data analysis and the availability of larger, representative cohorts, furthering refining the Pooled Cohort Equations, in addition to enhancers, would allow better risk estimation in segments of the population. Last, this scientific statement provides individual- and community-level intervention suggestions for health care professionals who interact with the Asian American population.
AbstractList Asian American individuals make up the fastest growing racial and ethnic group in the United States. Despite the substantial variability that exists in type 2 diabetes and atherosclerotic cardiovascular disease risk among the different subgroups of Asian Americans, the current literature, when available, often fails to examine these subgroups individually. The purpose of this scientific statement is to summarize the latest disaggregated data, when possible, on Asian American demographics, prevalence, biological mechanisms, genetics, health behaviors, acculturation and lifestyle interventions, pharmacological therapy, complementary alternative interventions, and their impact on type 2 diabetes and atherosclerotic cardiovascular disease. On the basis of available evidence to date, we noted that the prevalences of type 2 diabetes and stroke mortality are higher in all Asian American subgroups compared with non-Hispanic White adults. Data also showed that atherosclerotic cardiovascular disease risk is highest among South Asian and Filipino adults but lowest among Chinese, Japanese, and Korean adults. This scientific statement discusses the biological pathway of type 2 diabetes and the possible role of genetics in type 2 diabetes and atherosclerotic cardiovascular disease among Asian American adults. Challenges to provide evidence-based recommendations included the limited data on Asian American adults in risk prediction models, national surveillance surveys, and clinical trials, leading to significant research disparities in this population. The large disparity within this population is a call for action to the public health and clinical health care community, for whom opportunities for the inclusion of the Asian American subgroups should be a priority. Future studies of atherosclerotic cardiovascular disease risk in Asian American adults need to be adequately powered, to incorporate multiple Asian ancestries, and to include multigenerational cohorts. With advances in epidemiology and data analysis and the availability of larger, representative cohorts, furthering refining the Pooled Cohort Equations, in addition to enhancers, would allow better risk estimation in segments of the population. Last, this scientific statement provides individual- and community-level intervention suggestions for health care professionals who interact with the Asian American population.
Asian American individuals make up the fastest growing racial and ethnic group in the United States. Despite the substantial variability that exists in type 2 diabetes and atherosclerotic cardiovascular disease risk among the different subgroups of Asian Americans, the current literature, when available, often fails to examine these subgroups individually. The purpose of this scientific statement is to summarize the latest disaggregated data, when possible, on Asian American demographics, prevalence, biological mechanisms, genetics, health behaviors, acculturation and lifestyle interventions, pharmacological therapy, complementary alternative interventions, and their impact on type 2 diabetes and atherosclerotic cardiovascular disease. On the basis of available evidence to date, we noted that the prevalences of type 2 diabetes and stroke mortality are higher in all Asian American subgroups compared with non-Hispanic White adults. Data also showed that atherosclerotic cardiovascular disease risk is highest among South Asian and Filipino adults but lowest among Chinese, Japanese, and Korean adults. This scientific statement discusses the biological pathway of type 2 diabetes and the possible role of genetics in type 2 diabetes and atherosclerotic cardiovascular disease among Asian American adults. Challenges to provide evidence-based recommendations included the limited data on Asian American adults in risk prediction models, national surveillance surveys, and clinical trials, leading to significant research disparities in this population. The large disparity within this population is a call for action to the public health and clinical health care community, for whom opportunities for the inclusion of the Asian American subgroups should be a priority. Future studies of atherosclerotic cardiovascular disease risk in Asian American adults need to be adequately powered, to incorporate multiple Asian ancestries, and to include multigenerational cohorts. With advances in epidemiology and data analysis and the availability of larger, representative cohorts, furthering refining the Pooled Cohort Equations, in addition to enhancers, would allow better risk estimation in segments of the population. Last, this scientific statement provides individual- and community-level intervention suggestions for health care professionals who interact with the Asian American population.Asian American individuals make up the fastest growing racial and ethnic group in the United States. Despite the substantial variability that exists in type 2 diabetes and atherosclerotic cardiovascular disease risk among the different subgroups of Asian Americans, the current literature, when available, often fails to examine these subgroups individually. The purpose of this scientific statement is to summarize the latest disaggregated data, when possible, on Asian American demographics, prevalence, biological mechanisms, genetics, health behaviors, acculturation and lifestyle interventions, pharmacological therapy, complementary alternative interventions, and their impact on type 2 diabetes and atherosclerotic cardiovascular disease. On the basis of available evidence to date, we noted that the prevalences of type 2 diabetes and stroke mortality are higher in all Asian American subgroups compared with non-Hispanic White adults. Data also showed that atherosclerotic cardiovascular disease risk is highest among South Asian and Filipino adults but lowest among Chinese, Japanese, and Korean adults. This scientific statement discusses the biological pathway of type 2 diabetes and the possible role of genetics in type 2 diabetes and atherosclerotic cardiovascular disease among Asian American adults. Challenges to provide evidence-based recommendations included the limited data on Asian American adults in risk prediction models, national surveillance surveys, and clinical trials, leading to significant research disparities in this population. The large disparity within this population is a call for action to the public health and clinical health care community, for whom opportunities for the inclusion of the Asian American subgroups should be a priority. Future studies of atherosclerotic cardiovascular disease risk in Asian American adults need to be adequately powered, to incorporate multiple Asian ancestries, and to include multigenerational cohorts. With advances in epidemiology and data analysis and the availability of larger, representative cohorts, furthering refining the Pooled Cohort Equations, in addition to enhancers, would allow better risk estimation in segments of the population. Last, this scientific statement provides individual- and community-level intervention suggestions for health care professionals who interact with the Asian American population.
Author Wong, Sally S
Shah, Svati H
Deedwania, Prakash C
Hong, Yuling
Khaliq, Asma
Welty, Francine K
Kwan, Tak W
Khan, Sadiya S
Hayman, Laura L
Kanaya, Alka M
Palaniappan, Latha P
Author_xml – sequence: 1
  givenname: Tak W
  surname: Kwan
  fullname: Kwan, Tak W
– sequence: 2
  givenname: Sally S
  surname: Wong
  fullname: Wong, Sally S
– sequence: 3
  givenname: Yuling
  surname: Hong
  fullname: Hong, Yuling
– sequence: 4
  givenname: Alka M
  surname: Kanaya
  fullname: Kanaya, Alka M
– sequence: 5
  givenname: Sadiya S
  surname: Khan
  fullname: Khan, Sadiya S
– sequence: 6
  givenname: Laura L
  surname: Hayman
  fullname: Hayman, Laura L
– sequence: 7
  givenname: Svati H
  surname: Shah
  fullname: Shah, Svati H
– sequence: 8
  givenname: Francine K
  surname: Welty
  fullname: Welty, Francine K
– sequence: 9
  givenname: Prakash C
  surname: Deedwania
  fullname: Deedwania, Prakash C
– sequence: 10
  givenname: Asma
  surname: Khaliq
  fullname: Khaliq, Asma
– sequence: 11
  givenname: Latha P
  surname: Palaniappan
  fullname: Palaniappan, Latha P
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37154053$$D View this record in MEDLINE/PubMed
BookMark eNpNkd1KJDEQhYO4-LtvIJJLL2bcpDvpH--acUYHXBYc93qoTqrHSHcyJmnBd9yH2jgqWhdVh-LjnII6JvvWWSTkjLNLzgv-a7a8v2TfinMh98gRl5mYCpnX-9_0ITkO4SlBRV7KA3KYl1wKJvMj8m--NRoH43q3eaWuo9cGWowYKFhNm_iI3gXVpx6NojPw2rgXCGrswSc2IASkzeDshjbBgE0avVFvQo99DFd0OWz7tIjG2TChv8HCBge0cbJLWIxx9JicPKodckUbulImAaZLiasIcYfThXcDTfd8Jdwi-Jhig1Nm539KfnTQB_z5MU_I38X8YXY7vftzs5w1d1MleMWnULa866Ctc1FBposOtVQ1R9FWrCyZLphGkataqUqJmmVVKyDLpeaILGesy07Ixbvv1rvnEUNcDyYo7Huw6MawzirOZVFmnCX0_AMd2wH1euvNAP51_fmB7D_MR46u
CitedBy_id crossref_primary_10_1016_j_phymed_2024_156307
crossref_primary_10_1161_CIRCOUTCOMES_124_011097
crossref_primary_10_1186_s43682_025_00038_y
crossref_primary_10_1161_CIR_0000000000001278
crossref_primary_10_1161_CIR_0000000000001355
crossref_primary_10_1161_JAHA_124_037114
crossref_primary_10_1161_JAHA_124_037997
crossref_primary_10_3390_antiox12061311
crossref_primary_10_1007_s11883_025_01320_z
crossref_primary_10_1161_STROKEAHA_124_050380
crossref_primary_10_3390_antiox13121434
crossref_primary_10_1016_j_advnut_2024_100249
crossref_primary_10_1161_JAHA_123_032509
crossref_primary_10_1016_j_atherosclerosis_2025_119183
crossref_primary_10_1016_j_cjca_2024_04_001
crossref_primary_10_1016_j_amjcard_2024_01_029
crossref_primary_10_1038_s41433_025_03900_4
crossref_primary_10_1001_jamanetworkopen_2024_0734
crossref_primary_10_1016_j_focha_2025_101089
crossref_primary_10_3390_biomedicines12051019
crossref_primary_10_1016_j_freeradbiomed_2025_02_030
crossref_primary_10_1093_jpp_rgaf086
crossref_primary_10_1007_s11606_024_09126_6
crossref_primary_10_1016_j_focus_2025_100381
crossref_primary_10_1016_j_ipha_2024_05_004
crossref_primary_10_1016_j_ejphar_2025_178134
crossref_primary_10_1038_s41598_025_15183_6
crossref_primary_10_1109_JSEN_2024_3450838
crossref_primary_10_1016_j_cpcardiol_2023_102226
crossref_primary_10_1161_CIR_0000000000001258
crossref_primary_10_1186_s13019_024_02699_7
crossref_primary_10_1161_HYP_0000000000000248
crossref_primary_10_1016_j_bbadis_2024_167433
crossref_primary_10_1161_JAHA_124_037810
crossref_primary_10_1016_j_afres_2025_101056
crossref_primary_10_1186_s12889_025_23376_x
crossref_primary_10_1161_JAHA_124_038306
crossref_primary_10_4252_wjsc_v16_i12_1062
crossref_primary_10_1007_s11606_025_09767_1
crossref_primary_10_1016_j_clnu_2025_05_011
crossref_primary_10_1093_ajh_hpaf138
crossref_primary_10_1161_HYPERTENSIONAHA_124_24569
crossref_primary_10_1007_s40615_025_02341_9
crossref_primary_10_1001_jamanetworkopen_2024_35672
crossref_primary_10_1161_CIRCOUTCOMES_124_011440
crossref_primary_10_1186_s13690_023_01158_4
crossref_primary_10_1080_28355245_2025_2476134
crossref_primary_10_1136_bmjopen_2025_100339
crossref_primary_10_1007_s11886_025_02245_4
crossref_primary_10_1016_j_pcad_2024_05_002
crossref_primary_10_1007_s12170_024_00741_w
crossref_primary_10_1186_s12933_024_02405_w
crossref_primary_10_1016_j_cpan_2025_03_002
crossref_primary_10_1016_j_talanta_2024_126710
crossref_primary_10_1016_j_jacc_2025_08_001
crossref_primary_10_3389_fendo_2024_1383772
crossref_primary_10_3390_molecules29040758
crossref_primary_10_1007_s13300_024_01540_7
crossref_primary_10_3390_plants12193352
crossref_primary_10_2337_dci23_0068
crossref_primary_10_3390_ijerph22030404
crossref_primary_10_1212_WNL_0000000000213488
crossref_primary_10_1007_s40615_025_02354_4
crossref_primary_10_1080_1061186X_2025_2540849
crossref_primary_10_1161_CIR_0000000000001191
crossref_primary_10_1007_s11764_025_01786_5
crossref_primary_10_1253_circj_CJ_25_0086
crossref_primary_10_1038_s41598_025_98818_y
crossref_primary_10_1016_j_arteri_2025_500821
ContentType Journal Article
CorporateAuthor American Heart Association Council on Epidemiology and Prevention; Council on Lifestyle and Cardiometabolic Health; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and Council on Genomic and Precision Medicine
CorporateAuthor_xml – name: American Heart Association Council on Epidemiology and Prevention; Council on Lifestyle and Cardiometabolic Health; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and Council on Genomic and Precision Medicine
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1161/CIR.0000000000001145
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1524-4539
ExternalDocumentID 37154053
Genre Journal Article
Review
GeographicLocations United States
GeographicLocations_xml – name: United States
GroupedDBID ---
.-D
.3C
.XZ
.Z2
01R
0R~
0ZK
18M
1J1
29B
2FS
2WC
354
40H
4Q1
4Q2
4Q3
53G
5GY
5RE
5VS
6PF
71W
77Y
7O~
AAAAV
AAAXR
AAFWJ
AAGIX
AAHPQ
AAIQE
AAJCS
AAMOA
AAMTA
AAQKA
AARTV
AASCR
AASOK
AASXQ
AAUEB
AAWTL
AAXQO
ABASU
ABBUW
ABDIG
ABJNI
ABOCM
ABPMR
ABPXF
ABQRW
ABVCZ
ABXVJ
ABXYN
ABZAD
ABZZY
ACDDN
ACDOF
ACEWG
ACGFO
ACGFS
ACILI
ACLDA
ACOAL
ACRKK
ACWDW
ACWRI
ACXJB
ACXNZ
ACZKN
ADBBV
ADCYY
ADGGA
ADHPY
AE3
AE6
AEBDS
AENEX
AFBFQ
AFCHL
AFDTB
AFEXH
AFMBP
AFNMH
AFSOK
AFUWQ
AGINI
AHMBA
AHOMT
AHQNM
AHQVU
AHRYX
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJZMW
AKCTQ
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
ASPBG
AVWKF
AYCSE
AZFZN
BAWUL
BOYCO
BQLVK
BYPQX
C45
CGR
CS3
CUY
CVF
DIK
DIWNM
DU5
E3Z
EBS
ECM
EEVPB
EIF
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
GNXGY
GQDEL
GX1
H0~
HLJTE
HZ~
IKREB
IKYAY
IN~
IPNFZ
JF9
JG8
JK3
K-A
K-F
K8S
KD2
KMI
KQ8
L-C
L7B
N9A
NPM
N~7
N~B
O9-
OAG
OAH
OBH
OCB
ODMTH
OGEVE
OHH
OHYEH
OK1
OL1
OLB
OLG
OLH
OLU
OLV
OLY
OLZ
OPUJH
OVD
OVDNE
OVIDH
OVLEI
OVOZU
OWBYB
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P2P
PQQKQ
RAH
RIG
RLZ
S4R
S4S
T8P
TEORI
TR2
TSPGW
UPT
V2I
VVN
W2D
W3M
W8F
WH7
WOQ
WOW
X3V
X3W
XXN
XYM
YFH
YOC
YSK
YYM
YZZ
ZFV
ZY1
~H1
7X8
ADKSD
ADSXY
ID FETCH-LOGICAL-c4181-a7b1ffab9348a2d6fed5c91e4b80770d60de43c9cc8c49028b4a235d1ee0300f2
IEDL.DBID 7X8
ISICitedReferencesCount 70
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=00003017-202307040-00011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1524-4539
IngestDate Thu Oct 02 07:01:10 EDT 2025
Mon Jul 21 06:00:53 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords atherosclerosis
prevalence
diabetes mellitus, type 2
Asian
heart disease risk factors
AHA Scientific Statements
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4181-a7b1ffab9348a2d6fed5c91e4b80770d60de43c9cc8c49028b4a235d1ee0300f2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
PMID 37154053
PQID 2811567210
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2811567210
pubmed_primary_37154053
PublicationCentury 2000
PublicationDate 2023-Jul-04
20230704
PublicationDateYYYYMMDD 2023-07-04
PublicationDate_xml – month: 07
  year: 2023
  text: 2023-Jul-04
  day: 04
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Circulation (New York, N.Y.)
PublicationTitleAlternate Circulation
PublicationYear 2023
SSID ssj0006375
Score 2.6295218
SecondaryResourceType review_article
Snippet Asian American individuals make up the fastest growing racial and ethnic group in the United States. Despite the substantial variability that exists in type 2...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 74
SubjectTerms Adult
American Heart Association
Asian
Atherosclerosis - epidemiology
Atherosclerosis - therapy
Cardiovascular Diseases - epidemiology
Cardiovascular Diseases - therapy
Diabetes Mellitus, Type 2 - epidemiology
Diabetes Mellitus, Type 2 - therapy
Humans
United States - epidemiology
Title Epidemiology of Diabetes and Atherosclerotic Cardiovascular Disease Among Asian American Adults: Implications, Management, and Future Directions: A Scientific Statement From the American Heart Association
URI https://www.ncbi.nlm.nih.gov/pubmed/37154053
https://www.proquest.com/docview/2811567210
Volume 148
WOSCitedRecordID wos00003017-202307040-00011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS-wwFA5elYsb34-5PjiCuLLYNmmbuLmUwUEXDiIKsxvSPMCFrU5VmP94f9Q9yWSoLgTBLrpKk0K-nPMl58s5hJxIoW0ueBzFQgvcoBgWVUaKCPGUWsXQpWXKF5sohkM-GonbcODWBlnl3CZ6Q60b5c7Iz1OO3CXH_Ur89_klclWjXHQ1lND4RZYoUhmH6mLUZQvPqU-0iy6KRSyjIlydQ5Jz3r--m6UuDA9uC7KvSaZ3NoO1n_7mOlkNNBPKGS42yIKpN8lWWeMW-2kKp-CFn_5EfZP8vgnx9S3y77IrGDuFxkIQzLQgaw2lI4tNix1OGuwX-p-0rNjWx3qgdPWLoHS3M2EeEILS5floL-D6g4L9DDrxzZkfYeAznECww9jkAkrw5sdLmsBTY9ccBpPmCfB_uhGucM2-wge4bZOHweV9_yoK9R4iBAVPIllUibWyEpRxmercGp0pkRhW8bgoYp3H2jCqhFJcMZd1pmIypZlOjEFoxTbdIYt1U5s9AolCJ5xZo3JTMClpVUlhEyqzhBtesLxHjufTN8b15IIksjbNWzvuJrBHdmcYGD_PEn-MaZE4gkv_fOPrfbLiKtN7ZS87IEsWrYk5JMvq_fWxnRx5oOJ7eHvzHzLU9Vg
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Epidemiology+of+Diabetes+and+Atherosclerotic+Cardiovascular+Disease+Among+Asian+American+Adults%3A+Implications%2C+Management%2C+and+Future+Directions%3A+A+Scientific+Statement+From+the+American+Heart+Association&rft.jtitle=Circulation+%28New+York%2C+N.Y.%29&rft.au=Kwan%2C+Tak+W&rft.au=Wong%2C+Sally+S&rft.au=Hong%2C+Yuling&rft.au=Kanaya%2C+Alka+M&rft.date=2023-07-04&rft.eissn=1524-4539&rft.volume=148&rft.issue=1&rft.spage=74&rft_id=info:doi/10.1161%2FCIR.0000000000001145&rft_id=info%3Apmid%2F37154053&rft_id=info%3Apmid%2F37154053&rft.externalDocID=37154053
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1524-4539&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1524-4539&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1524-4539&client=summon